Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.
|
Mol Cell
|
2003
|
3.87
|
2
|
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription.
|
Nat Cell Biol
|
2005
|
3.79
|
3
|
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.
|
Blood
|
2002
|
3.00
|
4
|
In situ detection and genotyping of individual mRNA molecules.
|
Nat Methods
|
2010
|
2.29
|
5
|
In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method.
|
Mol Cell Proteomics
|
2007
|
2.10
|
6
|
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
|
Lancet
|
2002
|
1.97
|
7
|
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
|
Blood
|
2008
|
1.93
|
8
|
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.
|
Blood
|
2003
|
1.84
|
9
|
Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.
|
Blood
|
2004
|
1.77
|
10
|
Flow cytometric in situ proximity ligation analyses of protein interactions and post-translational modification of the epidermal growth factor receptor family.
|
Cytometry A
|
2009
|
1.73
|
11
|
Proximity ligation assays: a recent addition to the proteomics toolbox.
|
Expert Rev Proteomics
|
2010
|
1.70
|
12
|
Parallel visualization of multiple protein complexes in individual cells in tumor tissue.
|
Mol Cell Proteomics
|
2013
|
1.60
|
13
|
Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis.
|
Proc Natl Acad Sci U S A
|
2008
|
1.59
|
14
|
WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.
|
PLoS Biol
|
2010
|
1.57
|
15
|
Novel and highly recurrent chromosomal alterations in Sézary syndrome.
|
Cancer Res
|
2008
|
1.51
|
16
|
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.
|
EMBO J
|
2010
|
1.37
|
17
|
Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
|
J Cell Mol Med
|
2012
|
1.19
|
18
|
Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization.
|
J Pathol
|
2012
|
1.16
|
19
|
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
|
Leuk Lymphoma
|
2007
|
1.11
|
20
|
High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation.
|
Mol Cell Proteomics
|
2009
|
1.10
|
21
|
Visualising individual sequence-specific protein-DNA interactions in situ.
|
N Biotechnol
|
2011
|
1.10
|
22
|
Increasing the dynamic range of in situ PLA.
|
Nat Methods
|
2011
|
1.08
|
23
|
Proximity ligation assays for sensitive and specific protein analyses.
|
Anal Biochem
|
2005
|
1.07
|
24
|
MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas.
|
Glycobiology
|
2009
|
1.05
|
25
|
Molecular tools for a molecular medicine: analyzing genes, transcripts and proteins using padlock and proximity probes.
|
J Mol Recognit
|
2004
|
1.05
|
26
|
Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia.
|
Hum Mol Genet
|
2009
|
1.04
|
27
|
In situ proximity ligation assay for microscopy and flow cytometry.
|
Curr Protoc Cytom
|
2011
|
1.01
|
28
|
Analysis of protein interactions in situ by proximity ligation assays.
|
Curr Top Microbiol Immunol
|
2014
|
1.01
|
29
|
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
|
Blood
|
2003
|
1.00
|
30
|
In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay.
|
Nat Protoc
|
2013
|
0.99
|
31
|
Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation.
|
N Biotechnol
|
2012
|
0.97
|
32
|
Analysis of genes, transcripts, and proteins via DNA ligation.
|
Annu Rev Anal Chem (Palo Alto Calif)
|
2009
|
0.95
|
33
|
P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
|
J Pathol
|
2013
|
0.93
|
34
|
V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.
|
Leuk Lymphoma
|
2004
|
0.92
|
35
|
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma.
|
Int J Cancer
|
2011
|
0.91
|
36
|
Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.91
|
37
|
Padlock and proximity probes for in situ and array-based analyses: tools for the post-genomic era.
|
Comp Funct Genomics
|
2003
|
0.88
|
38
|
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.
|
Eur J Hum Genet
|
2012
|
0.87
|
39
|
Intercellular variation in signaling through the TGF-β pathway and its relation to cell density and cell cycle phase.
|
Mol Cell Proteomics
|
2012
|
0.85
|
40
|
Western blotting via proximity ligation for high performance protein analysis.
|
Mol Cell Proteomics
|
2011
|
0.85
|
41
|
Platelet-derived growth factor receptor expression and activation in choroid plexus tumors.
|
Am J Pathol
|
2009
|
0.84
|
42
|
U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
|
Eur J Haematol
|
2008
|
0.82
|
43
|
Simultaneous visualization of both signaling cascade activity and end-point gene expression in single cells.
|
PLoS One
|
2011
|
0.82
|
44
|
Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
|
Haematologica
|
2005
|
0.80
|
45
|
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
|
Leuk Res
|
2004
|
0.80
|
46
|
ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones.
|
PLoS One
|
2011
|
0.79
|
47
|
Molecular tools for companion diagnostics.
|
N Biotechnol
|
2012
|
0.79
|
48
|
Prospects for in situ analyses of individual and complexes of DNA, RNA, and protein molecules with padlock and proximity probes.
|
Methods Cell Biol
|
2004
|
0.79
|
49
|
Ligation-based molecular tools for lab-on-a-chip devices.
|
N Biotechnol
|
2008
|
0.78
|
50
|
Automated classification of multicolored rolling circle products in dual-channel wide-field fluorescence microscopy.
|
Cytometry A
|
2011
|
0.78
|
51
|
Thermoplastic microfluidic platform for single-molecule detection, cell culture, and actuation.
|
Anal Chem
|
2005
|
0.76
|
52
|
Association of the protein-tyrosine phosphatase DEP-1 with its substrate FLT3 visualized by in situ proximity ligation assay.
|
PLoS One
|
2013
|
0.76
|
53
|
Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell.
|
Immunol Lett
|
2004
|
0.76
|
54
|
Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments.
|
EPMA J
|
2012
|
0.76
|
55
|
Corrigendum: Insufficient antibody validation challenges oestrogen receptor beta research.
|
Nat Commun
|
2017
|
0.75
|
56
|
Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2007
|
0.75
|